Investigation of Chikungunya virus yields two new antigens for vaccine development

Credit: iStockphoto/Roger De Marfà

Chikungunya virus has caused epidemics in Africa, Asia and recently Europe. It is transmitted to humans by Aedes (see image), a genus of mosquitoes that also transmit dengue fever. Symptoms of a Chikungunya viral infection include acute fever followed by joint pain that can last for days, weeks, or even years. The disease may be fatal for newborns and the elderly; what’s worse is that there are no vaccines or treatments currently available for the disease.

Lucile Warter at the A*STAR’s Singapore Immunology Network and co-workers have now identified two regions of the virus recognized by human antibodies that can neutralize Chikungunya virus. The researchers have also shown the first proof that the virus is capable of direct cell-to-cell transmission. The findings could help explain how the virus avoids being bound by extracellular neutralizing antibodies and increases the efficiency of infection.

To discover the antibody-binding sites, researchers incubated the virus with previously identified antibodies and then isolated resistant variants. Sequencing and structural analysis revealed that the resistant variants had mutations in several regions, suggesting that these regions were the antibody binding sites. The mutations were in the viral fusion loop ‘groove,’ and the envelope E2 domain B. The latter domain has been shown to be important in neutralizing antibody recognition of related RNA viruses.

Results of analyses of the resistant strains, including rapid in vivo spread compared with wild-type virus, led the researchers to suspect that Chikungunya might be capable of direct cell-to-cell transmission. Warter and co-workers confirmed this hypothesis by culturing infected cells with uninfected cells in medium containing neutralizing antibodies. Many new cells became infected, but no viral particles were detectable outside the cells.

Microscopic examination of infected cells also showed increased concentrations of viral particles at points of cell-cell contact. Direct cell-to-cell transfer offers the advantage of spreading a large number of viral particles directly into another cell where they can begin reproducing, without the risks of traversing the extracellular space. This provides obvious advantages over the canonical mode of viral spread, broadcasting viral particles inside an organism.

“Chikungunya is the first alphavirus known to be capable of cell-to-cell transmission,” says Warter. “Additional studies will be necessary to identify molecular mechanisms associated with this route of transmission, as well as to investigate whether this kind of transmission occurs in vivo.”

More information: Lee, C. Y. et al. Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants. PLoS Pathogens 7, e1002390 (2011).

add to favorites email to friend print save as pdf

Related Stories

Elucidation of the 3D structure of Chikungunya virus

Dec 06, 2010

French researchers at the Pasteur Institute and the CNRS, in collaboration with the Synchrotron SOLEIL, have solved the three-dimensional structures of the glycoproteins that envelop the chikungunya virus. ...

Potential treatment for Chikungunya discovered

Feb 16, 2011

The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS, a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal ...

Human antibody for dengue virus isolated

Jun 22, 2012

(Phys.org) -- A group of scientists in Singapore and the UK have isolated a human antibody capable of effectively neutralizing the mosquito-borne dengue virus. Dengue fever is currently incurable and infects ...

Recommended for you

Where Ebola battles are won

8 hours ago

(HealthDay)—Four hospitals that are home to advanced biocontainment facilities have become America's ground zero in the treatment of Ebola patients.

Depression tied to worse lumbar spine surgery outcomes

11 hours ago

(HealthDay)—Depressive symptoms are associated with poorer long-term outcome in patients undergoing surgery for lumbar spinal stenosis (LSS), according to research published in the Oct. 1 issue of The Sp ...

Ebola death toll edging to 4,900 mark: WHO

11 hours ago

The death toll in the world's worst-ever Ebola outbreak has edged closer to 4,900, while almost 10,000 people have now been infected, new figures from the World Health Organization showed Wednesday.

US to track everyone coming from Ebola nations

12 hours ago

U.S. authorities said Wednesday that everyone traveling into the U.S. from Ebola-stricken nations will be monitored for symptoms for 21 days. That includes returning American aid workers, federal health employees ...

User comments